Understanding Patient Treatment Preferences in Clinical Trials
Author Information
Author(s): Nicola Mills, Jenny L. Donovan, Julia Wade, Freddie C. Hamdy, David E. Neal, J. Athene Lane
Primary Institution: University of Bristol
Hypothesis
How do patients' treatment preferences influence their participation in randomized controlled trials?
Conclusion
Exploring treatment preferences and providing evidence-based information can improve levels of informed decision making and facilitate RCT participation.
Supporting Evidence
- 69% of participants expressed treatment views early in appointments.
- Most participants became uncertain about their preferences after discussions.
- Exploration of preferences helped many participants make informed decisions.
Takeaway
When patients talk about their treatment choices, it helps them make better decisions about joining clinical trials.
Methodology
Qualitative analysis of audio recordings from recruitment appointments in a multicenter RCT.
Potential Biases
Potential for bias in how treatment preferences were interpreted by recruiters.
Limitations
The study was conducted within a single RCT, which may limit generalizability.
Participant Demographics
Participants were men aged 50-69, predominantly white, with varying socioeconomic statuses.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website